Cardiac Rhythm Management
banner cme webcast af2017

 

Activity Description

This activity features expert presentations and interactive discussions that assess current challenges and technological advancements to improve AF outcomes. The distinguished faculty examines the current state of AF and growing trends; including 3D mapping tools, contact force ablation, monitoring for AF, and optimal approaches for mapping persistent AF

Cardiac Rhythm Management

Access Presentation

Webcast

Click on the session title listed below to view each presentation.

For those wishing to obtain your continuing medical education certification, access Earn CME Credit Tab at the conclusion of the webcast; select the appropriate answer to each posttest question, and successfully obtain the passing score as designated at the top of the test.

AF2017 Mansour Pres

Perspectives on AF – Current State and Growing Trends

Moussa Mansour, MD, FACC, FHRS

play-webcast

Af2017 Rod Passman Pres

Monitoring for AF – Identifying Burden and Post AF Ablation Monitoring

Rod Passman, MD

play-webcast

AF2017 Isabel Deisenhofer Pres

Persistent AF – Different Approaches on Mapping: An Assessment of HD Mapping, Substrate Analysis, and Rotors or Triggers

Isabel Deisenhofer, MD

play-webcast

AF2017 Panel

Panel Discussion

Moderator: John Day, MD, FHRS, FACC
Panel:
Moussa Mansour, MD, FACC, FHRS, Rod Passman, MD, and Isabel Deisenhofer, MD

play-webcast

Cardiac Rhythm Management

Commercial Supporter

This activity is supported by an educational grant from St. Jude Medical

Sponsor

MediaSphere Medical, LLC and Cine-Med

 

Faculty

Faculty

AF2017 Day Port

John Day, MD, FHRS, FACC
Director of Heart Rhythm Services
Intermountain Medical Center
Salt Lake City, UT

AF2017 Isabel Deisenhofer Port

Isabel Deisenhofer, MD
Head, Department of Electrophysiology
Deputy-Head, Clinic of Cardiovascular Disease
German Heart Center Munich
Technical University of Munich (TUM)
Munich, Germany

AF2017 Mansur Port

Moussa Mansour, MD, FACC, FHRS
Director Cardiac Electrophysiology Laboratory,
Director Atrial Fibrillation Program
Massachusetts General Hospital
Boston, MA

AF2017 Rod Passman Port

Rod Passman, MD
Director, Bluhm Cardiovascular Center for Atrial Fibrillation
Professor of Medicine (Cardiology) and Preventive Medicine
Northwestern Memorial Hospital
Chicago, IL

 

CME Information

CME Released: 2/5/2017; Valid for credit through 2/5/2018

Target Audience

This activity has been developed to meet the educational needs of electrophysiologists, cardiologists and other physicians and associated professionals with an interest AF management.

Activity Goal

This activity is designed to address the following ABMS/IOM competencies: Patient Care, Medical Knowledge, and Practice-Based Learning.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Review the current state of AF and growing trends that may impact future care.
  • Examine the impact of 3D mapping tools, contact force ablation, and additional emerging techniques and technologies that may support improved outcomes.
  • Evaluate techniques and technologies for optimizing AF monitoring.
  • Assess different approaches for mapping persistent AF.

Accreditation Statement

This enduring activity has been planned and implemented in accordance with the essential areas and policies of the Accreditation Council for Continuing Medical Education through the joint-providership of Ciné-Med and MediaSphere Medical. Ciné-Med is accredited by the ACCME to provide continuing medical education for Physicians and is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Ciné-Med designates this educational activity for a maximum of 1 AMA PRA CATEGORY 1 Credit(s).
Physicians should only claim credit commensurate with the extent of their participation in the activity.

Ciné-Med designates this activity for 1 Contact Hour for Nurses.

Disclosure

MediaSphere Medical and Cine-Med adheres to accreditation requirements regarding industry support of continuing medical education. Disclosure of the planning committee and faculty's commercial relationships will be made known at the activity. Speakers are required to openly disclose any limitations of data and/or any discussion of any off-label, experimental, or investigational uses of drugs or devices in their presentations. All Cine-Med and MediaSphere Medical employees and planners in control of content have indicated that they have no relevant financial relationships to disclose.

Faculty Disclosure Summary

Dr. John Day discloses that he is a consultant for St. Jude Medical, Boston Scientific and BIOTRONIK.

Dr. Isabel Deisenhofer discloses that she receives speaker honoraria and travel grants from Biosense Webster, Inc., BIOTRONIK, St. Jude Medical, Boston Scientific, Bayer Healthcare, Böhringer-Ingelheim, Daiichi-Sankyo, and Bristol-Myers-Squibb.

Dr. Moussa Mansour discloses that he is a consultant for Biosense Webster, Inc., St. Jude Medical, Boston Scientific and Medtronic. He has also disclosed receiving research grants from Biosense Webster, Inc., and St. Jude Medical.

Dr. Rod Passman discloses he is on the speakers’ bureau and is a consultant for Medtronic and BIOTRONIK. He has also disclosed that he has received research grants from Medtronic.

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. This activity is designed to be completed within the time designated on the title page; physicians and nurses should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™ or Contact Hours, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and faculty disclosures.
  2. Review the educational presentations
  3. Select the appropriate answer to each posttest question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

Provider Contact Information

For technical support or CME/CE questions regarding this activity, please email us at This e-mail address is being protected from spambots. You need JavaScript enabled to view it .

Hardware/Software Requirements:

  • A computer with an Internet connection.
  • Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser.
  • Adobe Flash Player and/or an HTML5 capable browser may be required for video or audio playback.
  • Occasionally other additional software may be required such as PowerPoint or Adobe Acrobat Reader.

MediaSphere protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. MediaSphere and our joint sponsors will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency. MediaSphere maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2017 by MediaSphere Medical. All rights reserved. No part of this activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from MediaSphere Medical.

CME/CE Test

CME/CE Test
  1. Enhancing Outcomes with Technology Advancements in Treating AF
  2. Please enter your information, and complete the following CME post test and evaluation form. Upon successful completion, your submission will be reviewed and you will receive notification shortly regarding the status of your certificate. You must achieve a minimum score of 70% to earn credit for this activity.

  3. First Name: *  
    Invalid Input
  4. Last Name: *  
    Invalid Input
  5. Primary Email Address: *  
    Invalid Input
  6. Confirm Your Email: *  
    Invalid Input
  7. Degree: *  
    Invalid Input
  8. Institution: *  
    Invalid Input
  9. Mailing Address:*  
    Invalid Input
  10. City: *  
    Invalid Input
  11. State: *  
    Invalid Input

  12. 1. End point results from EFFICAS I surrounding the relationship been contact force and tissue recovery after ablation conclude that 20% of the segment around the Pulmonary Veins reconnect when the Force Time Integral (FTI) was less than 400gs, in contrast, when the FTI was greater than 400gs, just 5% of the segment around the Pulmonary Veins reconnected.
  13. Select one*  


    Invalid Input Please Select one

  14. 2. Which statement is accurate concerning results from TOCCASTAR as it relates to success rates when ablation was performed at optimal contact for vs non-optimal contact force.
  15. Select one*  




    Invalid Input Please Select one

  16. 3. Cost analysis data concludes that a 15% per patient cost reduction is attained in the year following ablation when optimal contact force is achieved using a contact force catheter as compared to patients treated with non-contact force sensing catheters.
  17. Select one*  


    Invalid Input Please Select one

  18. 4. Which statement is accurate surrounding the Efficacy, Safety, and Economic benefits of Contact Force Sensing?
  19. Select one*  





    Invalid Input Please Select one

  20. 5. Which statement is accurate based upon the mapping of persistent AF “wish list” developed by Dr. Isabel Deisenhofer?
  21. Select one*  





    Invalid Input Please Select one

  22. 6. Dr. Isabel Deisenhofer concludes within the presentation, Persistent AF – Different Approaches on Mapping: An Assessment of HD Mapping, Substrate Analysis, and Rotors or Triggers, that despite the availability of various mapping modalities, the main problem of understanding the true arrhythmogenic mechanism(s) in AF still exists?
  23. Select one*  


    Invalid Input Please Select one

  24. Although optional, we respectfully request that you complete the activity evaluation form, since your feedback assists in the development of future educational activities.

  25. Background

    Please rate each question using a scale of 1 to 5 (1 = Beginner, 5 = Advanced)


  26. I would consider my level of expertise in the subject matter prior to the webcast as:
    Invalid Input Please Select one

  27. I would consider my level of expertise in the subject matter after the activity
    Invalid Input

  28. Considering my experience and background, the material presented was:
    Invalid Input Please Select one

  29. Extent to which activity met the identified objectives
    Please rate each question using a scale of 1 to 5 (1 = Not Met, 5 = Completely Met)

  30. Review the current state of AF and growing trends that may impact future care.
    Invalid Input Please Select one

  31. Examine the impact of 3D mapping tools, contact force ablation, and additional emerging techniques and technologies that may support improved outcomes.
    Invalid Input Please Select one

  32. Evaluate techniques and technologies for optimizing AF monitoring.
    Invalid Input Please Select one

  33. Assess different approaches for mapping persistent AF.
    Invalid Input

  34. Information Presented
    Please evaluate the information that was presented by answering Yes, No, Maybe or Not Applicable

  35. Reinforced my current practice/treatment habits:
    Invalid Input Please Select one

  36. Will improve my practice/patient outcomes:
    Invalid Input Please Select one

  37. Enhanced my current knowledge base:
    Invalid Input Please Select one

  38. Provided new ideas or information that I expect to use:
    Invalid Input Please Select one

  39. Information gained from this conference will result in making a change in your practice:
    Invalid Input Please Select one

  40. Future activities on this subject matter is important to my practice:
    Invalid Input Please Select one

  41. Addressed a professional practice gap:
    Invalid Input Please Select one

  42. Was free of commercial bias/influence:
    Invalid Input Please Select one

  43. What barriers do you anticipate in incorporating best practices learned in this activity into clinical activities or quality improvement initiatives at your institution?
    Invalid Input

  44. What mechanisms can you identify to overcome these barriers?
    Invalid Input

  45. (*) Required Fields
  46. Invalid Input

Cardiac Rhythm Management